Missing Data for Rivaroxaban ATLAS ACS 2 TIMI 51 Follow‐up study and sensitivity analyses Xiang Sun, PhD Janssen Research - Janssen - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-11-30 21:07:13 Anticoagulants Morpholines Rivaroxaban Thiophenes Pharmacology Acute coronary syndrome Placebo Medicine Health Clinical research		Missing Data for Rivaroxaban ATLAS ACS 2 TIMI 51 Follow‐up study and sensitivity analyses Xiang Sun, PhD Janssen Research & Development LLC of Johnson & Johnson Add to Reading List Source URL: www.amstat.org Download Document from Source Website File Size: 245,34 KB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document